Conformable GORE® TAG® Thoracic Endoprosthesis 에 대한 현장 안전성 서한

Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI)에 따르면, 해당 현장 안전성 서한 는 Slovenia 에서 W. L. Gore & Associates, Inc. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

현장 안전성 서한은 의료기기 제조사 또는 제조사 대리인이 시중에 유통되고 있는 자사 의료기기 제품에 대하여 취할 수 있는 조치를 알리는 소통방식입니다. 주요 대상층은 보건의료업계 종사자와 의료기기 사용자들입니다. 여기에는 회수(recall) 조치와 경고도 포함될 수 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Field Safety Notice
  • 날짜
    2017-10-23
  • 사례 국가
  • 사례 출처
    AMPMDRS
  • 비고 / 경고
    Data from Slovenia is current through February 2019. All of the data comes from the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Slovenia.
  • 데이터 추가 비고
  • 원인
    • since december 2016, gore has received four similar reports of incomplete and / or partial deployments of the conformable tag® device. in each event, the physician observed that half of the conformable tag® device deployed and half remained constrained to the delivery catheter. each of these events occurred during an off-label procedure, but it is unclear at this time how this may have affected the outcomes. engineering evaluations for two returned devices indicate that one partial deployment was the result of an incorrect deployment line stitch pattern and another was the result of deployment line damage of unknown origin. the other two devices have not been returned to gore for evaluation. • there were two serious adverse health consequences and one death reported: – one patient required intra-operative surgical conversion and subsequently died. – one patient required intra-operative surgical conversion and experienced temporary mesenteric and renal ischemia. – one patient required an additional surgical intervention and experienced temporary renal ischemia. – one patient sustained no injuries due to deployment during an open repair. • while incomplete deployments are known adverse events and identified within the instructions for use (ifu), gore has seen an increased frequency of these partial deployment events in conformable tag® devices sold (totaling 0.03% of 12,865 devices distributed*) that were manufactured in the prior year compared to those manufactured earlier. .

Device

Manufacturer